NVX-CoV2372, monovalent mRNA and bivalent mRNA vaccines elicit broadly cross-reactive antibodies against emerging SARS-CoV-2 variants.
Saved in:
| Title: | NVX-CoV2372, monovalent mRNA and bivalent mRNA vaccines elicit broadly cross-reactive antibodies against emerging SARS-CoV-2 variants. |
|---|---|
| Authors: | Poh XY; Singapore Infectious Disease Clinical Research Network, Communicable Diseases Agency (CDA), Singapore, Singapore.; Clinical Trial Unit, NCID, Singapore, Singapore., Mah SYY; Emerging Infectious Diseases Programme, Duke-NUS Medical School, Singapore, Singapore., Yeoh AYY; Emerging Infectious Diseases Programme, Duke-NUS Medical School, Singapore, Singapore., Chavatte JM; National Public Health Laboratory, CDA, Singapore, Singapore., Lim DRX; National Public Health Laboratory, CDA, Singapore, Singapore., Tan CCY; National Public Health Laboratory, CDA, Singapore, Singapore., Tang HL; National Public Health Laboratory, CDA, Singapore, Singapore., Gandhi M; Singapore Clinical Research Institute, Consortium for Clinical Research and Innovation, Singapore, Singapore.; Centre for Quantitative Medicine, Duke-NUS Medical School, Singapore, Singapore., Rahman N; Singapore Clinical Research Institute, Consortium for Clinical Research and Innovation, Singapore, Singapore.; Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore., Rao S; Department of Infectious Diseases, National Centre for Infectious Diseases (NCID), Singapore, Singapore.; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore., Chia PY; Department of Infectious Diseases, National Centre for Infectious Diseases (NCID), Singapore, Singapore.; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore., Sadarangani SP; Department of Infectious Diseases, National Centre for Infectious Diseases (NCID), Singapore, Singapore.; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.; Clinical Advisor Office, CDA, Singapore, Singapore., Chin YQ; Clinical Trial Unit, NCID, Singapore, Singapore., Ng LFP; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; A*STAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore., Renia L; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.; A*STAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore., Lin RTP; National Public Health Laboratory, CDA, Singapore, Singapore., Lye DC; Department of Infectious Diseases, National Centre for Infectious Diseases (NCID), Singapore, Singapore.; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; CDA Research Group, CDA, Singapore, Singapore., Wang LF; Emerging Infectious Diseases Programme, Duke-NUS Medical School, Singapore, Singapore., Tan CW; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Young BE; Singapore Infectious Disease Clinical Research Network, Communicable Diseases Agency (CDA), Singapore, Singapore.; Clinical Trial Unit, NCID, Singapore, Singapore.; Department of Infectious Diseases, National Centre for Infectious Diseases (NCID), Singapore, Singapore.; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore. |
| Source: | Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2026 Dec; Vol. 22 (1), pp. 2638022. Date of Electronic Publication: 2026 May 05. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42083894 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: NVX-CoV2372, monovalent mRNA and bivalent mRNA vaccines elicit broadly cross-reactive antibodies against emerging SARS-CoV-2 variants. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Poh+XY%22">Poh XY</searchLink>; Singapore Infectious Disease Clinical Research Network, Communicable Diseases Agency (CDA), Singapore, Singapore.; Clinical Trial Unit, NCID, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Mah+SYY%22">Mah SYY</searchLink>; Emerging Infectious Diseases Programme, Duke-NUS Medical School, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Yeoh+AYY%22">Yeoh AYY</searchLink>; Emerging Infectious Diseases Programme, Duke-NUS Medical School, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Chavatte+JM%22">Chavatte JM</searchLink>; National Public Health Laboratory, CDA, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Lim+DRX%22">Lim DRX</searchLink>; National Public Health Laboratory, CDA, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Tan+CCY%22">Tan CCY</searchLink>; National Public Health Laboratory, CDA, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Tang+HL%22">Tang HL</searchLink>; National Public Health Laboratory, CDA, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Gandhi+M%22">Gandhi M</searchLink>; Singapore Clinical Research Institute, Consortium for Clinical Research and Innovation, Singapore, Singapore.; Centre for Quantitative Medicine, Duke-NUS Medical School, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Rahman+N%22">Rahman N</searchLink>; Singapore Clinical Research Institute, Consortium for Clinical Research and Innovation, Singapore, Singapore.; Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Rao+S%22">Rao S</searchLink>; Department of Infectious Diseases, National Centre for Infectious Diseases (NCID), Singapore, Singapore.; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Chia+PY%22">Chia PY</searchLink>; Department of Infectious Diseases, National Centre for Infectious Diseases (NCID), Singapore, Singapore.; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Sadarangani+SP%22">Sadarangani SP</searchLink>; Department of Infectious Diseases, National Centre for Infectious Diseases (NCID), Singapore, Singapore.; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.; Clinical Advisor Office, CDA, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Chin+YQ%22">Chin YQ</searchLink>; Clinical Trial Unit, NCID, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Ng+LFP%22">Ng LFP</searchLink>; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; A*STAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Renia+L%22">Renia L</searchLink>; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.; A*STAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Lin+RTP%22">Lin RTP</searchLink>; National Public Health Laboratory, CDA, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Lye+DC%22">Lye DC</searchLink>; Department of Infectious Diseases, National Centre for Infectious Diseases (NCID), Singapore, Singapore.; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; CDA Research Group, CDA, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Wang+LF%22">Wang LF</searchLink>; Emerging Infectious Diseases Programme, Duke-NUS Medical School, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Tan+CW%22">Tan CW</searchLink>; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Young+BE%22">Young BE</searchLink>; Singapore Infectious Disease Clinical Research Network, Communicable Diseases Agency (CDA), Singapore, Singapore.; Clinical Trial Unit, NCID, Singapore, Singapore.; Department of Infectious Diseases, National Centre for Infectious Diseases (NCID), Singapore, Singapore.; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101572652%22">Human vaccines & immunotherapeutics</searchLink> [Hum Vaccin Immunother] 2026 Dec; Vol. 22 (1), pp. 2638022. <i>Date of Electronic Publication: </i>2026 May 05. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101572652 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2164-554X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221645515%22">21645515 </searchLink><i>NLM ISO Abbreviation: </i>Hum Vaccin Immunother <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42083894 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/21645515.2026.2638022 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2638022 Titles: – TitleFull: NVX-CoV2372, monovalent mRNA and bivalent mRNA vaccines elicit broadly cross-reactive antibodies against emerging SARS-CoV-2 variants. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Poh XY – PersonEntity: Name: NameFull: Mah SYY – PersonEntity: Name: NameFull: Yeoh AYY – PersonEntity: Name: NameFull: Chavatte JM – PersonEntity: Name: NameFull: Lim DRX – PersonEntity: Name: NameFull: Tan CCY – PersonEntity: Name: NameFull: Tang HL – PersonEntity: Name: NameFull: Gandhi M – PersonEntity: Name: NameFull: Rahman N – PersonEntity: Name: NameFull: Rao S – PersonEntity: Name: NameFull: Chia PY – PersonEntity: Name: NameFull: Sadarangani SP – PersonEntity: Name: NameFull: Chin YQ – PersonEntity: Name: NameFull: Ng LFP – PersonEntity: Name: NameFull: Renia L – PersonEntity: Name: NameFull: Lin RTP – PersonEntity: Name: NameFull: Lye DC – PersonEntity: Name: NameFull: Wang LF – PersonEntity: Name: NameFull: Tan CW – PersonEntity: Name: NameFull: Young BE IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2026 Dec Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2164-554X Numbering: – Type: volume Value: 22 – Type: issue Value: 1 Titles: – TitleFull: Human vaccines & immunotherapeutics Type: main |
| ResultId | 1 |